TMCnet News

The MESI mTABLET ABI has been chosen as a finalist in the Cardiovascular Devices category in the 2021 Medical Design Excellence Awards competition
[April 29, 2021]

The MESI mTABLET ABI has been chosen as a finalist in the Cardiovascular Devices category in the 2021 Medical Design Excellence Awards competition


LJUBLJANA, Slovenia, April 29, 2021 /PRNewswire/ -- MESI mTABLET ABI, device used for early detection of Peripheral Arterial Disease (PAD) by measuring Ankle-Brachial Index (ABI), has been announced as a finalist in the Cardiovascular Device category in the 2021 Medical Design Awards (MDEA) competition. MDEA is the premier awards program for the MedTech industry. Since its inception in 1998, the mission of the MDEAs has been to recognize significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility.

Each year, a panel of jurors comprised of designers, engineers, and clinicians awards honours to the most innovative products on the market. MESI, with their innovative MESI mTABLET ABI medical device, competes in the category of Cardiovascular Devices. The winners will be announced on May 13 during the MedTech Design summit.

MESI mTABLET ABI is the smartest wireless Ankle-Brachial Index measurement device on the market. It allows simultaneous measurement of brachial and ankle pressures and detection of PAD i only 1 minute. This means that all patients at risk can receive the measurement on time, without unnecessary referrals, leading to timely treatment and preventing adverse events of PAD.



Due to the patented 3CUFF technology and PADsense algorithm, a reliable diagnostic result is guaranteed even in patients with low arterial perfusion. Besides its advanced technology for PAD detection, the MESI mTABLET ABI automatically saves the results of the measurement in the digital patient record, allowing the physician to monitor the patient's progress over time.

MESI mTABLET ABI is a part of the MESI mTABLET comprehensive system, that consists of wireless diagnostic modules, patient records, and software extensions offering additional diagnostic options. The system can be effortlessly introduced to any medical practice, as it is fully adaptable and modular. Besides ABI, the healthcare professionals can upgrade their practice with diagnostic modules, such as automated Toe-Brachial Index, 12-lead electrocardiogram, spirometry, pulse oximetry and blood pressure.


About the company:

MESI, Ltd. is an innovation-driven company located in Europe developing and producing medical devices for diagnostic purposes. MESI is focused on simplifying diagnostics, providing clinicians with predictive medical assessment, helping them discover diseases in the early stages and ensure all patients receive successful treatment. Our solutions fit into all medical environments, from individual practices to hospitals and home care. With strong in-house research & development and a certified production facility, we are a trustworthy provider of digital and connected diagnostic devices.

Contact:       
Manca Uršic Rosas
+386 51 656 292
manca@mesimedical.com

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/the-mesi-mtablet-abi-has-been-chosen-as-a-finalist-in-the-cardiovascular-devices-category-in-the-2021-medical-design-excellence-awards-competition-301279922.html

SOURCE MESI Ltd.


[ Back To TMCnet.com's Homepage ]